Home » Newsletters » BioWorld Science

BioWorld Science

June 22, 2017

View Archived Issues

FDA grants alirocumab orphan status for homozygous familial hypercholesterolemia

Apatinib mesylate receives U.S. orphan designation for treating gastric cancer

Burosumab granted FDA orphan drug status for tumor-induced osteomalacia syndrome

Sirnaomics' cotsiranib receives U.S. orphan status for primary sclerosing cholangitis

Porton Biopharma and NanoBio to advance intranasal anthrax vaccine

Leap Therapeutics to collaborate with Merck for evaluation of Keytruda in combination with DKN-01

First patient enrolled in a clinical trial evaluating treatment for mycetoma in Sudan

Daiichi Sankyo describes promising candidate for urinary tract infections, DS-86760016

Anti-KIR3DL2 monoclonal antibody IPH-4102 receives U.S. orphan designation

FDA names mirikizumab an orphan drug for the treatment of pediatric ulcerative colitis

Merck & Co. presents phase Ib results for rVSVdeltaG-ZEBOV-GP Ebola virus vaccine

Athera Biotechnologies' PC-mAb named U.S. orphan drug as company completes multiple-dosing study

GSK presents results from phase III study of revaccination with Shingrix

Preclinical data support entry of GyrB inhibitor DS-2969b into phase I development

EMA accepts Novartis' MAA filing for erenumab

Phase III cardiovascular risk reduction study of ACZ-885 meets primary endpoint

Identification of human MDA5 deficiency as a novel inborn error of innate and/or intrinsic immunity

Janssen enters agreement to use Adaptive Biotechnologies' assay in daratumumab studies

Sphingosine-1-phosphate is a potential marker of cystic fibrosis genotypes and presentation

GlaxoSmithKline describes novel hSTING modulators

CSIR identifies new CDK2/cyclin A and CDK9/cyclin-T1 inhibitors

Merck & Co. patents novel beta-secretase 1/2 inhibitors

Infuseon and OncoSynergy partner to test OS-2966 with Cleveland Multiport Catheter in glioblastoma

FDA gives orphan drug designation to pamrevlumab for pancreatic cancer

Kadimastem receives IRB approval for phase I/IIa trial of AstroRx in ALS

Novel mutation in INS gene tied to hereditary diabetes

DiAPREV-IT trial: first data for Alum-GAD for prevention of type 1 diabetes

FDA grants orphan drug designation to ibutamoren mesilate for growth hormone deficiency

EMA validates Veyvondi MAA

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...